about
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade dis...
Read More
12.60
-0.07
(-0.55%)
867.0K
XNAS Volume
XNAS 04 Dec, 2025 2:15 PM (EST)
Board Meeting
The board meeting for Arvinas Inc is scheduled for today, for the purpose of Piper Sandler 37th Annual Healthcare Conference
See details
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Arvinas Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..